2371:TSETatung Co., Ltd. Analysis
Data as of 2026-05-20 - not real-time
HK$0.22
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Chuanglian Holdings trades at HK$0.219, notably below its DCF‑derived fair value of HK$0.279 and its price‑to‑book of 0.94, suggesting a valuation gap despite weak profitability. The stock shows bearish technical signals – a 20‑day SMA (0.244) sits above the price, RSI is at 35 indicating oversold conditions, and the MACD histogram is negative – while volume is rising, hinting at potential short‑term buying interest near the support level of HK$0.21.
Fundamentally, revenue grew 11.5% YoY, yet the company posted a –6.9% profit margin, negative EBITDA and zero free cash flow, and carries a debt‑to‑equity of 29%, raising concerns about earnings sustainability. High 30‑day volatility (≈64%) and a historic max drawdown of 52% amplify risk, compounded by regulatory scrutiny on China’s education sector and a negative beta (‑0.36) that makes the stock move opposite to broader market trends.
Fundamentally, revenue grew 11.5% YoY, yet the company posted a –6.9% profit margin, negative EBITDA and zero free cash flow, and carries a debt‑to‑equity of 29%, raising concerns about earnings sustainability. High 30‑day volatility (≈64%) and a historic max drawdown of 52% amplify risk, compounded by regulatory scrutiny on China’s education sector and a negative beta (‑0.36) that makes the stock move opposite to broader market trends.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Bearish MACD and price below short‑term SMA
- Oversold RSI suggesting limited upside
- Proximity to technical support at HK$0.21
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation gap to DCF fair value
- Revenue growth versus ongoing losses
- Regulatory uncertainty in Chinese education
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained negative earnings and cash flow
- High sector and regulatory risk
- Potential for further price erosion if margins do not improve
Key Metrics & Analysis
Financial Health
Revenue Growth11.50%
Profit Margin-6.87%
Debt/Equity29.28
P/B Ratio0.9
Op. Cash FlowHK$9.1M
Technical Analysis
TrendBearish
RSI35.3
SupportHK$0.21
ResistanceHK$0.28
MA 20HK$0.24
MA 50HK$0.25
MA 200HK$0.31
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueHK$0.28
GradeUndervalued
TypeBlend
Risk Assessment
Beta-0.36
Volatility63.83%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.